Gilead Sciences On Track for Largest Percent Increase Since August 2023 — Data Talk
Gilead Sciences, Inc. (GILD) is currently at $65.45, up $2.30 or 3.64%
--Would be highest close since May 24, 2024, when it closed at $65.68
--On pace for largest percent increase since Aug. 4, 2023, when it rose 4.17%
--Snaps a two day losing streak
--Up 1.84% month-to-date
--Down 19.21% year-to-date
--Down 46.44% from its all-time closing high of $122.21 on June 23, 2015
--Down 16.21% from 52 weeks ago (June 22, 2023), when it closed at $78.11
--Down 25.02% from its 52-week closing high of $87.29 on Jan. 19, 2024
--Up 3.64% from its 52-week closing low of $63.15 on June 18, 2024
--Traded as high as $66.78; highest intraday level since May 23, 2024, when it hit $67.63
--Up 5.75% at today's intraday high; largest intraday percent increase since Aug. 4, 2023, when it rose as much as 6.1%
--Sixth best performer in the S&P 500 today
--Second best performer in the Nasdaq 100 today
All data as of 10:07:51 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 20, 2024 10:24 ET (14:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations